Compare GBX & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GBX | PRGO |
|---|---|---|
| Founded | 1974 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Railroads | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.4B |
| IPO Year | 1996 | 2013 |
| Metric | GBX | PRGO |
|---|---|---|
| Price | $47.95 | $10.08 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 2 | 3 |
| Target Price | ★ $49.00 | $19.33 |
| AVG Volume (30 Days) | 577.9K | ★ 3.9M |
| Earning Date | 04-07-2026 | 05-06-2026 |
| Dividend Yield | 2.85% | ★ 10.28% |
| EPS Growth | ★ 28.02 | N/A |
| EPS | ★ 2.21 | N/A |
| Revenue | ★ $3,240,200,000.00 | $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $8.74 | $1.02 |
| P/E Ratio | $21.55 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $38.23 | $9.23 |
| 52 Week High | $59.19 | $28.44 |
| Indicator | GBX | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 44.54 |
| Support Level | $47.46 | $9.29 |
| Resistance Level | $48.66 | $11.81 |
| Average True Range (ATR) | 1.61 | 0.50 |
| MACD | -0.07 | -0.01 |
| Stochastic Oscillator | 47.48 | 27.09 |
Greenbrier Companies Inc supplies equipment and services to international freight transportation markets, designing and marketing freight railcars in North America, Europe, and Brazil through subsidiaries and joint ventures. It provides railcar wheel services, parts, maintenance, and conversion services in North America. The company owns a lease fleet sourced mainly from its manufacturing operations and offers railcar management, regulatory compliance, and leasing services to railroads and owners. It operates two segments: Manufacturing and Leasing & Fleet Management, with the majority of revenue from Manufacturing. The company operates in the U.S. and internationally, with the majority of revenue from the U.S. market.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.